Entrada Therapeutics (TRDA) Return on Capital Employed [ROCE] (2021 - 2026)
Entrada Therapeutics' Return on Capital Employed [ROCE] was -59.67% in Q2 2026, down 38.20 percentage points from -21.47% a year earlier and down 6.77 percentage points from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Entrada Therapeutics came in at -36.94%, down 47.20 percentage points from FY2024.
- Return on Capital Employed [ROCE] shows a four-year change of -6.50 percentage points (FY2021 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was 10.26% in FY2024 (+11.82 pp), -1.57% in FY2023 (+36.28 pp), -37.84% in FY2022 (-7.40 pp) and -30.44% in FY2021.
- The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2021.
- Compared with a year earlier, Return on Capital Employed [ROCE] has declined for six straight quarters, with an average year-over-year change of -25.18 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2024 (a gain of 44.91 percentage points); the worst was Q1 2026 (a drop of 53.74 percentage points).
- Per Business Quant data, TRDA's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -52.90% (Q1 2026), -42.60% (Q4 2025) and -29.88% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Entrada Therapeutics | 221.16 Mn | 221.16 Mn | - | -59.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -59.67% |
| Mar 31, 2026 | -52.90% |
| Dec 31, 2025 | -42.60% |
| Sep 30, 2025 | -29.88% |
| Jun 30, 2025 | -21.47% |
| Mar 31, 2025 | 0.84% |
| Dec 31, 2024 | 9.38% |
| Sep 30, 2024 | 11.61% |
| Jun 30, 2024 | 20.29% |
| Mar 31, 2024 | 7.51% |
| Dec 31, 2023 | -0.99% |
| Sep 30, 2023 | -10.38% |
| Jun 30, 2023 | -20.51% |
| Mar 31, 2023 | -37.41% |
| Dec 31, 2022 | -40.30% |
| Sep 30, 2022 | -34.19% |
| Jun 30, 2022 | -27.25% |
| Mar 31, 2022 | -21.93% |
| Dec 31, 2021 | -24.07% |
API Access
Entrada Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();